| Product Code: ETC11530741 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Companion Diagnostic Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Companion Diagnostic Market - Industry Life Cycle |
3.4 Latvia Companion Diagnostic Market - Porter's Five Forces |
3.5 Latvia Companion Diagnostic Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Latvia Companion Diagnostic Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Companion Diagnostic Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Latvia Companion Diagnostic Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 Latvia Companion Diagnostic Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Latvia Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and targeted therapies |
4.2.2 Growing prevalence of chronic diseases in Latvia |
4.2.3 Advancements in diagnostic technologies and healthcare infrastructure |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High costs associated with companion diagnostic tests |
4.3.3 Limited awareness and adoption of companion diagnostics in Latvia |
5 Latvia Companion Diagnostic Market Trends |
6 Latvia Companion Diagnostic Market, By Types |
6.1 Latvia Companion Diagnostic Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Companion Diagnostic Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Latvia Companion Diagnostic Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Latvia Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry, 2021 - 2031F |
6.1.5 Latvia Companion Diagnostic Market Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031F |
6.1.6 Latvia Companion Diagnostic Market Revenues & Volume, By Mass Spectrometry, 2021 - 2031F |
6.2 Latvia Companion Diagnostic Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Companion Diagnostic Market Revenues & Volume, By Drug Response Testing, 2021 - 2031F |
6.2.3 Latvia Companion Diagnostic Market Revenues & Volume, By Biomarker Testing, 2021 - 2031F |
6.2.4 Latvia Companion Diagnostic Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.2.5 Latvia Companion Diagnostic Market Revenues & Volume, By Disease Identification, 2021 - 2031F |
6.3 Latvia Companion Diagnostic Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Latvia Companion Diagnostic Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.3 Latvia Companion Diagnostic Market Revenues & Volume, By Cardiology, 2021 - 2031F |
6.3.4 Latvia Companion Diagnostic Market Revenues & Volume, By Neurology, 2021 - 2031F |
6.3.5 Latvia Companion Diagnostic Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.4 Latvia Companion Diagnostic Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Latvia Companion Diagnostic Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Latvia Companion Diagnostic Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Latvia Companion Diagnostic Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Latvia Companion Diagnostic Market Revenues & Volume, By Urine, 2021 - 2031F |
6.5 Latvia Companion Diagnostic Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Latvia Companion Diagnostic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Latvia Companion Diagnostic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5.4 Latvia Companion Diagnostic Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Latvia Companion Diagnostic Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
7 Latvia Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Latvia Companion Diagnostic Market Export to Major Countries |
7.2 Latvia Companion Diagnostic Market Imports from Major Countries |
8 Latvia Companion Diagnostic Market Key Performance Indicators |
8.1 Number of clinical trials incorporating companion diagnostics in Latvia |
8.2 Adoption rate of companion diagnostics by healthcare providers in Latvia |
8.3 Investment in research and development of new companion diagnostic technologies in Latvia |
9 Latvia Companion Diagnostic Market - Opportunity Assessment |
9.1 Latvia Companion Diagnostic Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Latvia Companion Diagnostic Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Companion Diagnostic Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.4 Latvia Companion Diagnostic Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.5 Latvia Companion Diagnostic Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Latvia Companion Diagnostic Market - Competitive Landscape |
10.1 Latvia Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Latvia Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here